首页 > 最新文献

中华眼科杂志最新文献

英文 中文
[Enhancing the understanding and clinical management of intraocular space-occupying lesions]. [提高对眼内占位性病变的认识和临床处理]。
Q3 Medicine Pub Date : 2026-01-11 DOI: 10.3760/cma.j.cn112142-20250420-00190
W B Wei, N Zhou

In medical practice, intraocular space-occupying lesions are a major category of diseases that are prone to clinical misdiagnosis and mistreatment. In the process of diagnosing these lesions caused by different etiologies, special attention should be paid to the establishment of diagnostic and therapeutic thinking patterns and clinical diagnosis, and vigilance should be exercised against the negative trend of using auxiliary examination results instead of clinical diagnosis. Ophthalmologists should enhance their understanding of intraocular space-occupying lesions, make accurate diagnoses, choose appropriate treatments, and perform enucleation surgery with caution.

在医疗实践中,眼内占位性病变是临床上容易误诊和误治的一类主要疾病。在对这些不同病因引起的病变进行诊断的过程中,应特别注意诊疗思维模式的建立和临床诊断,警惕以辅助检查结果代替临床诊断的消极倾向。眼科医生应提高对眼内占位性病变的认识,准确诊断,选择合适的治疗方法,谨慎行眼球摘除术。
{"title":"[Enhancing the understanding and clinical management of intraocular space-occupying lesions].","authors":"W B Wei, N Zhou","doi":"10.3760/cma.j.cn112142-20250420-00190","DOIUrl":"10.3760/cma.j.cn112142-20250420-00190","url":null,"abstract":"<p><p>In medical practice, intraocular space-occupying lesions are a major category of diseases that are prone to clinical misdiagnosis and mistreatment. In the process of diagnosing these lesions caused by different etiologies, special attention should be paid to the establishment of diagnostic and therapeutic thinking patterns and clinical diagnosis, and vigilance should be exercised against the negative trend of using auxiliary examination results instead of clinical diagnosis. Ophthalmologists should enhance their understanding of intraocular space-occupying lesions, make accurate diagnoses, choose appropriate treatments, and perform enucleation surgery with caution.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"62 1","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical efficacy of 12 o'clock peripheral iridectomy in aphakic eyes undergoing pars plana vitrectomy with heavy silicone oil tamponade]. [重型硅油填塞下12点钟方向周围虹膜切除术在无晶状眼玻璃体切割术中的临床疗效]。
Q3 Medicine Pub Date : 2026-01-11 DOI: 10.3760/cma.j.cn112142-20250620-00280
J L Dong, X G Zhang, S N Xu, X Zhang, B Jiang, D W Sun
<p><p><b>Objective:</b> To investigate the clinical effect of performing a 12 o'clock peripheral iridectomy during vitrectomy with heavy silicone oil tamponade in aphakic eyes. <b>Methods:</b> This was a prospective controlled study. Patients diagnosed with tractional retinal detachment secondary to proliferative diabetic retinopathy and scheduled to undergo combined lens extraction and pars plana vitrectomy with heavy silicone oil tamponade at the Department of Ophthalmology, Second Affiliated Hospital of Harbin Medical University between January and December 2024 were enrolled in this study. Patients were randomly assigned, using a random number table, to either the combined group (undergoing aphakic vitrectomy with heavy silicone oil tamponade and a 12 o'clock peripheral iridectomy) or the simple group (undergoing aphakic vitrectomy with heavy silicone oil tamponade but without a peripheral iridectomy). Intraocular pressure (IOP) and best-corrected visual acuity (BCVA) were recorded preoperatively and at 1 day, 1, 4, and 12 weeks postoperatively. These measures, along with postoperative silicone oil migration into the anterior chamber, corneal condition, retinal reattachment status, and other complications, were compared between the two groups. Statistical analyses were performed using the independent-samples <i>t</i>-test, independent-samples Mann-Whitney <i>U</i> test, and chi-square (<i>χ</i>²) test. <b>Results:</b> A total of 20 patients (20 eyes) were enrolled, including 11 males (11 eyes) and 9 females (9 eyes), with a mean age of (59.65±8.92) years (range, 46 to 78 years). There were 10 eyes in each of the combined and simple groups. No statistically significant differences were found between the two groups in terms of age, BCVA, or IOP at baseline (all <i>P</i>>0.05). At 1, 4, and 12 weeks postoperatively, the IOP in the combined group [(20.78±4.06), (20.82±3.67), and (21.00±3.14) mmHg; 1 mmHg=0.133 kPa] was significantly lower than that in the simple group [(25.15±4.63), (28.52±8.12), and (29.80±8.34) mmHg], with statistically significant differences at all time points (all <i>P</i><0.05). There were no statistically significant differences in BCVA between the two groups at any postoperative time point (all <i>P</i>>0.05). Silicone oil migration into the anterior chamber occurred in only one eye in the combined group at 12 weeks postoperatively, whereas in the simple group, 0, 2, 5, and 7 eyes exhibited silicone oil in the anterior chamber at 1 day, 1, 4, and 12 weeks, respectively. Regarding corneal edema (grade≥1), the number of affected eyes in the combined group was 3, 1, 1, and 1 at the corresponding time points, while in the simple group it was 3, 2, 5, and 6, respectively. Additionally, at 12 weeks postoperatively, one eye in the simple group showed persistent retinal detachment, and one eye in the combined group exhibited closure of the peripheral iridectomy incision. <b>Conclusion:</b> Performing a 12 o'clock peripheral iride
目的:探讨无晶状眼玻璃体切除术中重度硅油填塞行12点钟方向虹膜周围切除术的临床效果。方法:前瞻性对照研究。本研究纳入哈尔滨医科大学第二附属医院眼科于2024年1月至12月诊断为增殖性糖尿病视网膜病变继发牵引性视网膜脱离并计划行重硅油填塞联合晶状体摘除术及玻璃体滑膜部切除术的患者。采用随机数字表将患者随机分配到联合组(行无囊玻璃体切除术伴重硅油填塞和12点钟方向虹膜周围切除术)或简单组(行无囊玻璃体切除术伴重硅油填塞但不伴虹膜周围切除术)。术前、术后1天、1周、4周、12周分别记录眼内压(IOP)和最佳矫正视力(BCVA)。这些措施,以及术后硅油向前房的迁移、角膜状况、视网膜再附着状态和其他并发症,在两组之间进行比较。统计学分析采用独立样本t检验、独立样本Mann-Whitney U检验和χ 2检验。结果:共入组患者20例(20眼),其中男性11例(11眼),女性9例(9眼),平均年龄(59.65±8.92)岁(范围46 ~ 78岁)。组合组和简单组各有10只眼睛。两组患者的年龄、BCVA、IOP基线值差异无统计学意义(P < 0.05)。术后1、4、12周,联合组IOP分别为(20.78±4.06)、(20.82±3.67)、(21.00±3.14)mmHg;1 mmHg=0.133 kPa]明显低于单纯组[(25.15±4.63)、(28.52±8.12)、(29.80±8.34)mmHg],各时间点差异均有统计学意义(p < 0.05)。术后12周,联合组仅有1只眼出现前房硅油迁移,而单纯组在术后1天、1周、4周和12周分别有0、2、5和7只眼出现前房硅油迁移。对于角膜水肿(≥1级),联合组相应时间点受累眼数分别为3、1、1、1只,单纯组分别为3、2、5、6只。此外,在术后12周,单眼组的一只眼出现持续的视网膜脱离,联合组的一只眼出现周围虹膜切除切口闭合。结论:在无晶状眼玻璃体切除术中进行重度硅油填塞的12点钟方向虹膜周围切除术,可有效控制术后IOP,减少硅油向前房迁移的发生率,减轻术后并发症,提高手术安全性。
{"title":"[Clinical efficacy of 12 o'clock peripheral iridectomy in aphakic eyes undergoing pars plana vitrectomy with heavy silicone oil tamponade].","authors":"J L Dong, X G Zhang, S N Xu, X Zhang, B Jiang, D W Sun","doi":"10.3760/cma.j.cn112142-20250620-00280","DOIUrl":"10.3760/cma.j.cn112142-20250620-00280","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objective:&lt;/b&gt; To investigate the clinical effect of performing a 12 o'clock peripheral iridectomy during vitrectomy with heavy silicone oil tamponade in aphakic eyes. &lt;b&gt;Methods:&lt;/b&gt; This was a prospective controlled study. Patients diagnosed with tractional retinal detachment secondary to proliferative diabetic retinopathy and scheduled to undergo combined lens extraction and pars plana vitrectomy with heavy silicone oil tamponade at the Department of Ophthalmology, Second Affiliated Hospital of Harbin Medical University between January and December 2024 were enrolled in this study. Patients were randomly assigned, using a random number table, to either the combined group (undergoing aphakic vitrectomy with heavy silicone oil tamponade and a 12 o'clock peripheral iridectomy) or the simple group (undergoing aphakic vitrectomy with heavy silicone oil tamponade but without a peripheral iridectomy). Intraocular pressure (IOP) and best-corrected visual acuity (BCVA) were recorded preoperatively and at 1 day, 1, 4, and 12 weeks postoperatively. These measures, along with postoperative silicone oil migration into the anterior chamber, corneal condition, retinal reattachment status, and other complications, were compared between the two groups. Statistical analyses were performed using the independent-samples &lt;i&gt;t&lt;/i&gt;-test, independent-samples Mann-Whitney &lt;i&gt;U&lt;/i&gt; test, and chi-square (&lt;i&gt;χ&lt;/i&gt;²) test. &lt;b&gt;Results:&lt;/b&gt; A total of 20 patients (20 eyes) were enrolled, including 11 males (11 eyes) and 9 females (9 eyes), with a mean age of (59.65±8.92) years (range, 46 to 78 years). There were 10 eyes in each of the combined and simple groups. No statistically significant differences were found between the two groups in terms of age, BCVA, or IOP at baseline (all &lt;i&gt;P&lt;/i&gt;&gt;0.05). At 1, 4, and 12 weeks postoperatively, the IOP in the combined group [(20.78±4.06), (20.82±3.67), and (21.00±3.14) mmHg; 1 mmHg=0.133 kPa] was significantly lower than that in the simple group [(25.15±4.63), (28.52±8.12), and (29.80±8.34) mmHg], with statistically significant differences at all time points (all &lt;i&gt;P&lt;/i&gt;&lt;0.05). There were no statistically significant differences in BCVA between the two groups at any postoperative time point (all &lt;i&gt;P&lt;/i&gt;&gt;0.05). Silicone oil migration into the anterior chamber occurred in only one eye in the combined group at 12 weeks postoperatively, whereas in the simple group, 0, 2, 5, and 7 eyes exhibited silicone oil in the anterior chamber at 1 day, 1, 4, and 12 weeks, respectively. Regarding corneal edema (grade≥1), the number of affected eyes in the combined group was 3, 1, 1, and 1 at the corresponding time points, while in the simple group it was 3, 2, 5, and 6, respectively. Additionally, at 12 weeks postoperatively, one eye in the simple group showed persistent retinal detachment, and one eye in the combined group exhibited closure of the peripheral iridectomy incision. &lt;b&gt;Conclusion:&lt;/b&gt; Performing a 12 o'clock peripheral iride","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"62 1","pages":"18-25"},"PeriodicalIF":0.0,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Focusing on the challenges and opportunities of optical coherence tomography in the diagnosis and treatment of fundus diseases]. 【聚焦光学相干断层扫描在眼底疾病诊治中的挑战与机遇】。
Q3 Medicine Pub Date : 2026-01-11 DOI: 10.3760/cma.j.cn112142-20250324-00128
M X Zhang, C Y Lei

Optical coherence tomography (OCT), with its advantages of non-invasiveness, non-contact, rapid imaging, and high resolution, has become an indispensable core imaging tool in the diagnosis and treatment of fundus diseases. It provides clinicians with critical structural insights for accurately assessing lesion characteristics and severity, dynamically monitoring disease progression and treatment efficacy, and optimizing therapeutic strategies. However, in the era of precision medicine, the application effectiveness of OCT still faces significant challenges. Deeply understanding and acknowledging its limitations is fundamental to maximizing the value of OCT and seeking effective solutions. This article focuses on the key bottlenecks and breakthrough paths of OCT in the diagnosis and treatment of fundus diseases, systematically analyzing the core issues from three dimensions, including the physical constraints of the device itself, the physiological and pathological variations among individual patients, and the subjectivity of physician interpretation. Closely following the cutting-edge trends and development opportunities in the OCT field, the counter strategies, like continuous technological innovation, deep integration of artificial intelligence, multimodal imaging integration, optimization of patient workflows and protocols, and standardized physician training, are also discussed. The aim is to provide clinicians with a comprehensive insight into the current status and future directions of OCT applications, helping them better understand existing challenges, more effectively utilize current technologies, and grasp the opportunities brought by technological innovation and diagnostic model transformation, and thus promoting the continuous improvement of precision diagnosis and treatment levels for fundus diseases.

光学相干断层扫描(Optical coherence tomography, OCT)以其无创、非接触、成像速度快、分辨率高等优点,已成为眼底疾病诊断和治疗中不可缺少的核心成像工具。它为临床医生提供了准确评估病变特征和严重程度、动态监测疾病进展和治疗效果以及优化治疗策略的关键结构见解。然而,在精准医疗时代,OCT的应用效果仍面临重大挑战。深刻理解和承认其局限性是实现OCT价值最大化和寻求有效解决方案的基础。本文围绕OCT在眼底疾病诊治中的关键瓶颈和突破路径,从设备本身的物理约束、个体患者的生理病理差异、医师解读的主观性三个维度系统分析核心问题。并紧跟着OCT领域的前沿趋势和发展机遇,探讨了持续技术创新、人工智能深度融合、多模式影像融合、优化患者工作流程和方案、规范化医师培训等应对策略。旨在让临床医生全面了解OCT应用的现状和未来发展方向,帮助他们更好地了解存在的挑战,更有效地利用现有技术,把握技术创新和诊断模式转变带来的机遇,从而促进眼底疾病精准诊断和治疗水平的不断提高。
{"title":"[Focusing on the challenges and opportunities of optical coherence tomography in the diagnosis and treatment of fundus diseases].","authors":"M X Zhang, C Y Lei","doi":"10.3760/cma.j.cn112142-20250324-00128","DOIUrl":"10.3760/cma.j.cn112142-20250324-00128","url":null,"abstract":"<p><p>Optical coherence tomography (OCT), with its advantages of non-invasiveness, non-contact, rapid imaging, and high resolution, has become an indispensable core imaging tool in the diagnosis and treatment of fundus diseases. It provides clinicians with critical structural insights for accurately assessing lesion characteristics and severity, dynamically monitoring disease progression and treatment efficacy, and optimizing therapeutic strategies. However, in the era of precision medicine, the application effectiveness of OCT still faces significant challenges. Deeply understanding and acknowledging its limitations is fundamental to maximizing the value of OCT and seeking effective solutions. This article focuses on the key bottlenecks and breakthrough paths of OCT in the diagnosis and treatment of fundus diseases, systematically analyzing the core issues from three dimensions, including the physical constraints of the device itself, the physiological and pathological variations among individual patients, and the subjectivity of physician interpretation. Closely following the cutting-edge trends and development opportunities in the OCT field, the counter strategies, like continuous technological innovation, deep integration of artificial intelligence, multimodal imaging integration, optimization of patient workflows and protocols, and standardized physician training, are also discussed. The aim is to provide clinicians with a comprehensive insight into the current status and future directions of OCT applications, helping them better understand existing challenges, more effectively utilize current technologies, and grasp the opportunities brought by technological innovation and diagnostic model transformation, and thus promoting the continuous improvement of precision diagnosis and treatment levels for fundus diseases.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"62 1","pages":"5-13"},"PeriodicalIF":0.0,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The importance of scleral buckling for rhegmatogenous retinal detachment]. 巩膜扣带对孔源性视网膜脱离的重要性。
Q3 Medicine Pub Date : 2026-01-11 DOI: 10.3760/cma.j.cn112142-20250325-00139
P Q Zhao, W T Zhang, J Peng

The management of rhegmatogenous retinal detachment (RRD) primarily relies on two core surgical modalities: scleral buckling (SB) and pars plana vitrectomy (PPV). In recent years, the rapid advancement of PPV technology has facilitated its increasingly widespread clinical application. However, due to its steep learning curve, SB has become progressively marginalized in clinical practice. In some instances, it has even been substituted for cases that were originally indicated for SB. This article systematically analyzes the unique complications and indications of both surgical approaches, highlighting the irreplaceable value of SB in specific patient populations, such as pediatric patients and those with moderately complex RRD in phakic eyes. It is proposed that the selection of surgical strategy should be based on a comprehensive evaluation of lesion characteristics, patient-specific factors, and the inherent advantages of each technique, thereby enabling individualized and precise treatment.

孔源性视网膜脱离(RRD)的治疗主要依赖于两种核心手术方式:巩膜屈曲(SB)和玻璃体切割(PPV)。近年来,PPV技术的快速发展促进了其临床应用的日益广泛。然而,由于其陡峭的学习曲线,SB在临床实践中逐渐被边缘化。在某些情况下,它甚至被取代了最初适用于SB的病例。本文系统地分析了两种手术方法的独特并发症和适应症,强调了SB在特定患者群体中不可替代的价值,例如儿科患者和患有中度复杂的晶状眼RRD的患者。建议在选择手术策略时,应综合评估病变特征、患者特异性因素以及每种技术的内在优势,从而实现个体化和精准治疗。
{"title":"[The importance of scleral buckling for rhegmatogenous retinal detachment].","authors":"P Q Zhao, W T Zhang, J Peng","doi":"10.3760/cma.j.cn112142-20250325-00139","DOIUrl":"10.3760/cma.j.cn112142-20250325-00139","url":null,"abstract":"<p><p>The management of rhegmatogenous retinal detachment (RRD) primarily relies on two core surgical modalities: scleral buckling (SB) and pars plana vitrectomy (PPV). In recent years, the rapid advancement of PPV technology has facilitated its increasingly widespread clinical application. However, due to its steep learning curve, SB has become progressively marginalized in clinical practice. In some instances, it has even been substituted for cases that were originally indicated for SB. This article systematically analyzes the unique complications and indications of both surgical approaches, highlighting the irreplaceable value of SB in specific patient populations, such as pediatric patients and those with moderately complex RRD in phakic eyes. It is proposed that the selection of surgical strategy should be based on a comprehensive evaluation of lesion characteristics, patient-specific factors, and the inherent advantages of each technique, thereby enabling individualized and precise treatment.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"62 1","pages":"14-17"},"PeriodicalIF":0.0,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chinese expert consensus on the clinical application of therapeutic bandage contact lenses (2025)]. 【中国治疗性绷带隐形眼镜临床应用专家共识(2025)】。
Q3 Medicine Pub Date : 2025-11-11 DOI: 10.3760/cma.j.cn112142-20250621-00282

In recent years, therapeutic bandage contact lenses have been widely used in clinical practice. In 2019, the Society of Contact Lens Safety Monitoring and Visual Health of Chinese Health Association formulated expert consensus opinions on their standardized clinical application. Over the past five years, new progress has been achieved in the related research. Therefore, the society has conducted extensive discussions to attain an updated consensus on the indications, contraindications and usages of therapeutic bandage contact lenses based on the latest evidence-based medicine and clinical discoveries and experience, which may serve as a reference for clinical practitioners.

近年来,治疗性绷带隐形眼镜已广泛应用于临床。2019年,中国卫生协会隐形眼镜安全监测与视力健康分会制定了隐形眼镜规范临床应用的专家共识意见。近五年来,相关研究取得了新的进展。因此,基于最新的循证医学和临床发现与经验,社会各界进行了广泛的讨论,对治疗性绷带隐形眼镜的适应症、禁忌症和使用方法达成了最新的共识,可供临床从业人员参考。
{"title":"[Chinese expert consensus on the clinical application of therapeutic bandage contact lenses (2025)].","authors":"","doi":"10.3760/cma.j.cn112142-20250621-00282","DOIUrl":"10.3760/cma.j.cn112142-20250621-00282","url":null,"abstract":"<p><p>In recent years, therapeutic bandage contact lenses have been widely used in clinical practice. In 2019, the Society of Contact Lens Safety Monitoring and Visual Health of Chinese Health Association formulated expert consensus opinions on their standardized clinical application. Over the past five years, new progress has been achieved in the related research. Therefore, the society has conducted extensive discussions to attain an updated consensus on the indications, contraindications and usages of therapeutic bandage contact lenses based on the latest evidence-based medicine and clinical discoveries and experience, which may serve as a reference for clinical practitioners.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"61 11","pages":"845-853"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145496867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A dialectical analysis of the clinical activity score for thyroid-associated ophthalmopathy]. 甲状腺相关性眼病临床活动度评分的辨证分析
Q3 Medicine Pub Date : 2025-11-11 DOI: 10.3760/cma.j.cn112142-20250106-00006
J Qian, H S Yang, R L Wei

The clinical activity score (CAS) for the thyroid-associated ophthalmopathy (TAO) evaluation has advantages such as simplicity and practicality for clinical use, but it also has limitations. Based on the formulation and development of the CAS, this article analyzes five aspects: design limitations, ethnic differences, comparison with the VISA (vision, inflammation, strabismus, and appearance/exposure) classification, controversies regarding CAS cutoff values, and the lack of objectivity in the CAS. It emphasizes that clinicians should comprehensively and dialectically evaluate the CAS by integrating the disease course, severity, and harmfulness of TAO, so as to correctly distinguish TAO stages, provide appropriate treatments, achieve favorable therapeutic effects, and ultimately improve the clinical management of TAO.

临床活动度评分(CAS)评价甲状腺相关性眼病(TAO)具有简单、实用等优点,但也存在局限性。本文以CAS的制定和发展为基础,分析了五个方面:设计局限性、种族差异、与VISA(视力、炎症、斜视和外观/暴露)分类的比较、关于CAS截止值的争议以及CAS缺乏客观性。强调临床医生应综合TAO的病程、严重程度、危害性对CAS进行全面、辩证的评价,以正确区分TAO的分期,给予适当的治疗,达到良好的治疗效果,最终提高TAO的临床管理水平。
{"title":"[A dialectical analysis of the clinical activity score for thyroid-associated ophthalmopathy].","authors":"J Qian, H S Yang, R L Wei","doi":"10.3760/cma.j.cn112142-20250106-00006","DOIUrl":"10.3760/cma.j.cn112142-20250106-00006","url":null,"abstract":"<p><p>The clinical activity score (CAS) for the thyroid-associated ophthalmopathy (TAO) evaluation has advantages such as simplicity and practicality for clinical use, but it also has limitations. Based on the formulation and development of the CAS, this article analyzes five aspects: design limitations, ethnic differences, comparison with the VISA (vision, inflammation, strabismus, and appearance/exposure) classification, controversies regarding CAS cutoff values, and the lack of objectivity in the CAS. It emphasizes that clinicians should comprehensively and dialectically evaluate the CAS by integrating the disease course, severity, and harmfulness of TAO, so as to correctly distinguish TAO stages, provide appropriate treatments, achieve favorable therapeutic effects, and ultimately improve the clinical management of TAO.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"61 11","pages":"839-844"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145496613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Lesion detection in optical coherence tomography based on lightweight convolutional neural networks]. [基于轻量级卷积神经网络的光学相干断层成像损伤检测]。
Q3 Medicine Pub Date : 2025-11-11 DOI: 10.3760/cma.j.cn112142-20241130-00544
H Z Cheng, X Wang, X R Ning, Y D Shen, S W Kang, S L Li, J Zhong

Objective: To achieve automated lesion detection in optical coherence tomography (OCT) images based on a lightweight convolutional neural network architecture. Methods: This retrospective study employed deep learning to construct a lightweight lesion identification model using OCT images from Sichuan Provincial People's Hospital alongside datasets including OCT-C8, OCT-2017, and HD-OCT of MH. Model performance evaluation comprised two stages: firstly, testing on four independent external validation sets to assess the model's generalisability and accuracy; secondly, employing a confidence interval overlap comparison method to evaluate the classification performance of ophthalmologists at different levels of clinical experience (two per level) against the model, thereby determining the clinical experience level corresponding to the model's medical proficiency. Results: The model achieved an accuracy of 93.41% (47 054/50 374) on the validation set, with an F1 score of 88.18% (44 419/50 374) and a recall rate of 86.42% (43 533/50 374). The area under the receiver operating characteristic curve was 99.31% (50 026/50 374), with precision at 91.48% (46 082/50 374) and specificity at 99.1% (49 921/50 374). For nine categories of OCT images, namely neovascularisation, posterior vitreous detachment, epiretinal membrane, macular hole, macular schisis, subretinal fluid, normal image, vitreomacular traction, and obscured image, the precision rates were 97.48% (16 873/17 310), 90.99% (3 039/3 340), 97.62% (1 325/1 358), 97.91% (2 185/2 232), 79.23% (4 961/6 262), 81.47% (1 594/1 957), 90.55% (17 744/19 596), 88.08% (237/269), and 99.95% (19 520/19 530), respectively. The model achieved an average accuracy of 89.9% on the external validation set, whereas junior physicians demonstrated an accuracy of 74% (95%CI: 61.84%~86.16%) in interpreting OCT images, and that of mid-level physicians was 88% (95%CI: 78.99%~97.01%), indicating the model's performance approached that of mid-level physicians. Conclusions: This study marks the first successful implementation of automated recognition across nine categories of OCT images. Its clinical performance has preliminarily attained the level of a mid-career physician, and it can be deployed locally within healthcare settings to enhance diagnostic efficiency and accuracy.

目的:实现基于轻量级卷积神经网络架构的光学相干断层扫描(OCT)图像病灶自动检测。方法:采用回顾性研究方法,利用四川省人民医院OCT图像,结合OCT- c8、OCT-2017和MH -OCT数据集构建轻量级病变识别模型。模型性能评估分为两个阶段:首先,在四个独立的外部验证集上进行测试,以评估模型的通用性和准确性;其次,采用置信区间重叠比较法对模型评价不同临床经验水平(每级2名)的眼科医生的分类表现,从而确定与模型的医疗熟练程度相对应的临床经验水平。结果:该模型在验证集上的准确率为93.41% (47 054/50 374),F1分数为88.18%(44 419/50 374),召回率为86.42%(43 533/50 374)。受试者工作特征曲线下面积为99.31%(50 026/50 374),精密度为91.48%(46 082/50 374),特异性为99.1%(49 921/50 374)。对新生血管、玻璃体后脱离、视网膜前膜、黄斑裂孔、黄斑裂片、视网膜下液、正常影像、玻璃体黄斑拖着、模糊影像9类OCT图像,准确率分别为97.48%(16 873/17 310)、90.99%(3 039/3 340)、97.62%(1 325/1 358)、97.91%(2 186 /2 232)、79.23%(4 961/6 262)、81.47%(1 594/1 957)、90.55%(17 744/19 596)、88.08%(237/269)、99.95%(19 520/19 530)。模型在外部验证集上的平均准确率为89.9%,而初级医生的OCT图像解释准确率为74% (95%CI: 61.84%~86.16%),中级医生的准确率为88% (95%CI: 78.99%~97.01%),表明模型的性能接近中级医生的水平。结论:本研究首次成功实现了九类OCT图像的自动识别。其临床表现已初步达到职业生涯中期医生的水平,可在当地医疗机构部署,以提高诊断效率和准确性。
{"title":"[Lesion detection in optical coherence tomography based on lightweight convolutional neural networks].","authors":"H Z Cheng, X Wang, X R Ning, Y D Shen, S W Kang, S L Li, J Zhong","doi":"10.3760/cma.j.cn112142-20241130-00544","DOIUrl":"10.3760/cma.j.cn112142-20241130-00544","url":null,"abstract":"<p><p><b>Objective:</b> To achieve automated lesion detection in optical coherence tomography (OCT) images based on a lightweight convolutional neural network architecture. <b>Methods:</b> This retrospective study employed deep learning to construct a lightweight lesion identification model using OCT images from Sichuan Provincial People's Hospital alongside datasets including OCT-C8, OCT-2017, and HD-OCT of MH. Model performance evaluation comprised two stages: firstly, testing on four independent external validation sets to assess the model's generalisability and accuracy; secondly, employing a confidence interval overlap comparison method to evaluate the classification performance of ophthalmologists at different levels of clinical experience (two per level) against the model, thereby determining the clinical experience level corresponding to the model's medical proficiency. <b>Results:</b> The model achieved an accuracy of 93.41% (47 054/50 374) on the validation set, with an F1 score of 88.18% (44 419/50 374) and a recall rate of 86.42% (43 533/50 374). The area under the receiver operating characteristic curve was 99.31% (50 026/50 374), with precision at 91.48% (46 082/50 374) and specificity at 99.1% (49 921/50 374). For nine categories of OCT images, namely neovascularisation, posterior vitreous detachment, epiretinal membrane, macular hole, macular schisis, subretinal fluid, normal image, vitreomacular traction, and obscured image, the precision rates were 97.48% (16 873/17 310), 90.99% (3 039/3 340), 97.62% (1 325/1 358), 97.91% (2 185/2 232), 79.23% (4 961/6 262), 81.47% (1 594/1 957), 90.55% (17 744/19 596), 88.08% (237/269), and 99.95% (19 520/19 530), respectively. The model achieved an average accuracy of 89.9% on the external validation set, whereas junior physicians demonstrated an accuracy of 74% (95%<i>CI</i>: 61.84%~86.16%) in interpreting OCT images, and that of mid-level physicians was 88% (95%<i>CI</i>: 78.99%~97.01%), indicating the model's performance approached that of mid-level physicians. <b>Conclusions:</b> This study marks the first successful implementation of automated recognition across nine categories of OCT images. Its clinical performance has preliminarily attained the level of a mid-career physician, and it can be deployed locally within healthcare settings to enhance diagnostic efficiency and accuracy.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"61 11","pages":"896-903"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145496889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Progress on predictive biomarkers for exudation in polypoidal choroidal vasculopathy]. [息肉样脉络膜血管病变渗出物预测生物标志物研究进展]。
Q3 Medicine Pub Date : 2025-11-11 DOI: 10.3760/cma.j.cn112142-20250416-00186
Y Hong, Q Y Bo, X D Sun

Polypoidal choroidal vasculopathy (PCV) is a common subtype of neovascular age-related macular degeneration (nAMD) in Asian populations. Clinical follow-up has revealed varying degrees of activity in PCV lesions. Studies have shown that multimodal retinal imaging techniques can be used to assess the activity of PCV lesions. Abnormal branching vascular networks, polypoidal lesions, and choroidal-related features are important biological markers for predicting lesion activity. Additionally, demographic characteristics and genetic traits of patients may also serve as relevant factors for assessing the activity of PCV lesions. This review summarizes recent updates in the understanding of PCV lesion activity based on multimodal retinal imaging studies and their impact on clinical ophthalmic practice. It also explores the potential applications and prospects of lesion activity characteristics in the treatment and follow-up of PCV, aiming to provide reference for clinicians in assessing and determining the activity of PCV lesions and developing personalized treatment and follow-up plans.

息肉样脉络膜血管病变(PCV)是亚洲人群中新生血管性年龄相关性黄斑变性(nAMD)的一种常见亚型。临床随访显示PCV病变有不同程度的活动性。研究表明,多模态视网膜成像技术可用于评估PCV病变的活动性。异常分支血管网络、息肉样病变和脉络膜相关特征是预测病变活动的重要生物学标志物。此外,患者的人口统计学特征和遗传特征也可能是评估PCV病变活动性的相关因素。本文综述了基于多模态视网膜成像研究对PCV病变活动性的最新认识及其对临床眼科实践的影响。探讨病变活动性特征在PCV治疗和随访中的潜在应用和前景,为临床医生评估和确定PCV病变活动性,制定个性化治疗和随访方案提供参考。
{"title":"[Progress on predictive biomarkers for exudation in polypoidal choroidal vasculopathy].","authors":"Y Hong, Q Y Bo, X D Sun","doi":"10.3760/cma.j.cn112142-20250416-00186","DOIUrl":"10.3760/cma.j.cn112142-20250416-00186","url":null,"abstract":"<p><p>Polypoidal choroidal vasculopathy (PCV) is a common subtype of neovascular age-related macular degeneration (nAMD) in Asian populations. Clinical follow-up has revealed varying degrees of activity in PCV lesions. Studies have shown that multimodal retinal imaging techniques can be used to assess the activity of PCV lesions. Abnormal branching vascular networks, polypoidal lesions, and choroidal-related features are important biological markers for predicting lesion activity. Additionally, demographic characteristics and genetic traits of patients may also serve as relevant factors for assessing the activity of PCV lesions. This review summarizes recent updates in the understanding of PCV lesion activity based on multimodal retinal imaging studies and their impact on clinical ophthalmic practice. It also explores the potential applications and prospects of lesion activity characteristics in the treatment and follow-up of PCV, aiming to provide reference for clinicians in assessing and determining the activity of PCV lesions and developing personalized treatment and follow-up plans.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"61 11","pages":"915-920"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145497033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Four cases of severe orbital cellulitis in children]. [儿童重度眼眶蜂窝织炎4例]。
Q3 Medicine Pub Date : 2025-11-11 DOI: 10.3760/cma.j.cn112142-20250205-00054
Y W Fan, D Cao, L Li

Four children were treated at the Ophthalmology Department of Beijing Children's Hospital affiliated with Capital Medical University, including a female patient aged 9 years and 11 months with redness and swelling of the forehead accompanied by bilateral eyelid swelling for 3 days, a male 14-day-old infant with progressive worsening of the right eye redness and swelling accompanied by high fever, nasal congestion and a runny nose for 7 days, a boy aged 5 years and 9 months with the left eye and facial redness and swelling, black skin deposition, rupture, pus discharge and high fever for 2 days, and a 7-year-old male with the right eyelid redness and swelling accompanied by fever and acute lymphoblastic leukemia for 2 hours. The comprehensive blood routine examination showed C-reactive protein levels exceeded 140 mg/L and white blood cell counts exceeded 20×109/L in all patients. Bacterial cultures of ocular secretions or pus were mainly positive for Streptococcus pyogenes, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. Orbital imaging revealed orbital abscess formation (Chandler stage 4) in 2 patients and subperiosteal abscess and necrotizing fasciitis (Chandler stage 3) in 2 patients. According to the scoring criteria for the systemic inflammatory response syndrome, all four cases were diagnosed with severe orbital cellulitis. Systemic and ocular antibiotics were administered, along with local debridement and abscess incision and drainage. Four children recovered without any recurrence of infection. Two of them developed late-onset inner canthal deformity and eyelid abnormality, which were resolved by corrective surgery.

4名患儿在首都医科大学附属北京儿童医院眼科就诊,其中女患儿9岁11个月,额头红肿伴双眼睑肿胀3天,男患儿14日龄,右眼红肿进行性加重伴高热、鼻塞、流鼻涕7天。男1例,5岁9个月,左眼及面部红肿,皮肤积黑,破裂,脓流,高热2天,7岁男1例,右眼眼睑红肿,伴发热,急性淋巴细胞白血病2小时。综合血常规检查显示,所有患者c反应蛋白水平均超过140 mg/L,白细胞计数均超过20×109/L。眼部分泌物或脓液细菌培养以化脓性链球菌、鲍曼不动杆菌、耐甲氧西林金黄色葡萄球菌和铜绿假单胞菌为主。眼眶影像学显示2例眼眶脓肿形成(Chandler期4),2例骨膜下脓肿和坏死性筋膜炎(Chandler期3)。根据全身性炎症反应综合征评分标准,4例均诊断为重度眼眶蜂窝织炎。给予全身和眼部抗生素,同时局部清创和脓肿切口和引流。4例患儿痊愈,无感染复发。其中2例出现迟发性内眦畸形及眼睑畸形,均经手术矫正。
{"title":"[Four cases of severe orbital cellulitis in children].","authors":"Y W Fan, D Cao, L Li","doi":"10.3760/cma.j.cn112142-20250205-00054","DOIUrl":"10.3760/cma.j.cn112142-20250205-00054","url":null,"abstract":"<p><p>Four children were treated at the Ophthalmology Department of Beijing Children's Hospital affiliated with Capital Medical University, including a female patient aged 9 years and 11 months with redness and swelling of the forehead accompanied by bilateral eyelid swelling for 3 days, a male 14-day-old infant with progressive worsening of the right eye redness and swelling accompanied by high fever, nasal congestion and a runny nose for 7 days, a boy aged 5 years and 9 months with the left eye and facial redness and swelling, black skin deposition, rupture, pus discharge and high fever for 2 days, and a 7-year-old male with the right eyelid redness and swelling accompanied by fever and acute lymphoblastic leukemia for 2 hours. The comprehensive blood routine examination showed C-reactive protein levels exceeded 140 mg/L and white blood cell counts exceeded 20×10<sup>9</sup>/L in all patients. Bacterial cultures of ocular secretions or pus were mainly positive for Streptococcus pyogenes, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. Orbital imaging revealed orbital abscess formation (Chandler stage 4) in 2 patients and subperiosteal abscess and necrotizing fasciitis (Chandler stage 3) in 2 patients. According to the scoring criteria for the systemic inflammatory response syndrome, all four cases were diagnosed with severe orbital cellulitis. Systemic and ocular antibiotics were administered, along with local debridement and abscess incision and drainage. Four children recovered without any recurrence of infection. Two of them developed late-onset inner canthal deformity and eyelid abnormality, which were resolved by corrective surgery.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"61 11","pages":"904-910"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145496873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The efficacy of topotecan versus topotecan combined with melphalan in the treatment of vitreous seeds in retinoblastoma]. 拓扑替康与拓扑替康联合美伐兰治疗视网膜母细胞瘤玻璃体种子的疗效比较。
Q3 Medicine Pub Date : 2025-11-11 DOI: 10.3760/cma.j.cn112142-20250604-00264
X T Lin, H F Chen, Q Liu, H Yue, J Qian, K Xue
<p><p><b>Objective:</b> To comparatively evaluate the efficacy and safety of intravitreal topotecan (IVT) versus intravitreal melphalan (IVM) combined with IVT in the treatment of vitreous seeds in retinoblastoma (RB). <b>Methods:</b> Retrospective cohort study. This study collected clinical data from 34 patients with unilateral vitreous seeds in RB who were diagnosed and treated at the Department of Ophthalmology of Eye & ENT Hospital of Fudan University from December 2015 to May 2025. All patients developed refractory or recurrent vitreous seeds after receiving intravenous chemotherapy or intra-arterial chemotherapy. Baseline data, ocular characteristics and detailed treatment histories were analyzed. Patients were treated with IVT (single-drug group) or IVT combined with IVM (double-drug group), which was administered at 4-week intervals until the vitreous seeds disappeared or became stably calcified. The primary outcome measures were the control of vitreous seeds and the globe-salvage rate. The ocular and systemic adverse effects following intravitreal chemotherapy were also recorded. Statistical analyses were performed using the <i>t</i> test, the Mann-Whitney <i>U</i> test and the <i>χ</i>² test. The Kaplan-Meier method was used to plot globe-salvage curves and differences were compared using the log-rank test. <b>Results:</b> There were 21 (61.8%) males and 13 (38.2%) females. The median age at initial diagnosis was 29.5 (19.5, 38.0) months. Among them, 8 (23.5%) had bilateral RB, all with unilateral vitreous seeds and the affected eye received intravitreal chemotherapy and 26 (76.5%) had unilateral RB. Of the affected eyes, 15 (44.1%) were left eyes and 19 (55.9%) were right eyes. According to the International Intraocular Classification of Retinoblastoma, 13 (38.2%) eyes were classified as group E, 20 (58.8%) as group D, and 1 (3.0%) as group C. The single-drug group included 15 eyes (44.1%), with a median age at initial diagnosis of 21.0 (11.0, 30.0) months and a follow-up duration of 19.0±10.0 months. Among them, 1 eye was classified as group C, 7 eyes as group D, and 7 eyes as group E. Each affected eye received a mean of 3.1±1.1 intravitreal injections, with a total topotecan dose of 89.3±34.3 μg per eye. The double-drug group included 19 eyes (55.9%), with a median age at initial diagnosis of 33.0 (22.0, 42.0) months and a follow-up duration of 67.9±30.4 months. Among them, 13 eyes were classified as group D and 6 eyes as group E. Each affected eye received a mean of 5.0±1.7 intravitreal injections, with a total melphalan dose of 111.1±44.5 μg and a total topotecan dose of 74.7±44.0 μg per eye. During the follow-up period, vitreous seeds in all affected eyes in both groups were controlled (100%), and no orbital or systemic metastases were observed. Compared with the double-drug group, the single-drug group exhibited fewer local adverse effects. The incidence of cataract was 0/15 and 9/19, while the incidence of phthisis bulbi was 0/
目的:比较玻璃体内注射topotecan (IVT)与玻璃体内注射melphalan (IVM)联合IVT治疗视网膜母细胞瘤(RB)玻璃体种子的疗效和安全性。方法:回顾性队列研究。本研究收集2015年12月至2025年5月在复旦大学眼耳鼻喉医院眼科诊治的34例单侧RB玻璃体种子患者的临床资料。所有患者在接受静脉化疗或动脉化疗后均出现难治性或复发性玻璃体微粒。分析基线数据、眼部特征和详细的治疗史。患者采用IVT(单药组)或IVT联合IVM(双药组)治疗,每隔4周给药,直至玻璃体种子消失或稳定钙化。主要观察指标为玻璃体种子的控制和全球抢救率。同时记录玻璃体内化疗后的眼部和全身不良反应。采用t检验、Mann-Whitney U检验和χ 2检验进行统计分析。Kaplan-Meier法绘制全球救助曲线,采用log-rank检验比较差异。结果:男性21例(61.8%),女性13例(38.2%)。初诊时的中位年龄为29.5(19.5,38.0)个月。其中双侧RB 8例(23.5%),均为单侧玻璃体种子,受累眼均行玻璃体内化疗,单侧RB 26例(76.5%)。其中左眼15例(44.1%),右眼19例(55.9%)。根据国际视网膜母细胞瘤眼内分类,E组13只(38.2%),D组20只(58.8%),c组1只(3.0%)。单药组15只(44.1%)眼,初诊时中位年龄21.0(11.0,30.0)个月,随访时间19.0±10.0个月。其中1只眼为C组,7只眼为D组,7只眼为e组,每只眼平均接受3.1±1.1次玻璃体内注射,topotecan总剂量为89.3±34.3 μg /眼。双药组19只眼(55.9%),初诊时中位年龄33.0(22.0,42.0)个月,随访时间67.9±30.4个月。其中D组13只眼,e组6只眼,平均每只眼接受玻璃体内注射5.0±1.7次,美伐兰总剂量为111.1±44.5 μg,拓扑替康总剂量为74.7±44.0 μg /只眼。随访期间,两组患眼玻璃体种子均得到控制(100%),未见眼眶或全身转移。与双药组相比,单药组局部不良反应较少。白内障的发生率分别为0/15和9/19,球炎的发生率分别为0/15和6/19 (p < 0.05)。单药组和双药组的最终全球挽回率分别为14/15和14/19。结论:体外移植术能有效治疗RB玻璃体种子。与美法兰联合治疗方案相比,IVT单药治疗的眼内不良反应较少。
{"title":"[The efficacy of topotecan versus topotecan combined with melphalan in the treatment of vitreous seeds in retinoblastoma].","authors":"X T Lin, H F Chen, Q Liu, H Yue, J Qian, K Xue","doi":"10.3760/cma.j.cn112142-20250604-00264","DOIUrl":"10.3760/cma.j.cn112142-20250604-00264","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objective:&lt;/b&gt; To comparatively evaluate the efficacy and safety of intravitreal topotecan (IVT) versus intravitreal melphalan (IVM) combined with IVT in the treatment of vitreous seeds in retinoblastoma (RB). &lt;b&gt;Methods:&lt;/b&gt; Retrospective cohort study. This study collected clinical data from 34 patients with unilateral vitreous seeds in RB who were diagnosed and treated at the Department of Ophthalmology of Eye & ENT Hospital of Fudan University from December 2015 to May 2025. All patients developed refractory or recurrent vitreous seeds after receiving intravenous chemotherapy or intra-arterial chemotherapy. Baseline data, ocular characteristics and detailed treatment histories were analyzed. Patients were treated with IVT (single-drug group) or IVT combined with IVM (double-drug group), which was administered at 4-week intervals until the vitreous seeds disappeared or became stably calcified. The primary outcome measures were the control of vitreous seeds and the globe-salvage rate. The ocular and systemic adverse effects following intravitreal chemotherapy were also recorded. Statistical analyses were performed using the &lt;i&gt;t&lt;/i&gt; test, the Mann-Whitney &lt;i&gt;U&lt;/i&gt; test and the &lt;i&gt;χ&lt;/i&gt;² test. The Kaplan-Meier method was used to plot globe-salvage curves and differences were compared using the log-rank test. &lt;b&gt;Results:&lt;/b&gt; There were 21 (61.8%) males and 13 (38.2%) females. The median age at initial diagnosis was 29.5 (19.5, 38.0) months. Among them, 8 (23.5%) had bilateral RB, all with unilateral vitreous seeds and the affected eye received intravitreal chemotherapy and 26 (76.5%) had unilateral RB. Of the affected eyes, 15 (44.1%) were left eyes and 19 (55.9%) were right eyes. According to the International Intraocular Classification of Retinoblastoma, 13 (38.2%) eyes were classified as group E, 20 (58.8%) as group D, and 1 (3.0%) as group C. The single-drug group included 15 eyes (44.1%), with a median age at initial diagnosis of 21.0 (11.0, 30.0) months and a follow-up duration of 19.0±10.0 months. Among them, 1 eye was classified as group C, 7 eyes as group D, and 7 eyes as group E. Each affected eye received a mean of 3.1±1.1 intravitreal injections, with a total topotecan dose of 89.3±34.3 μg per eye. The double-drug group included 19 eyes (55.9%), with a median age at initial diagnosis of 33.0 (22.0, 42.0) months and a follow-up duration of 67.9±30.4 months. Among them, 13 eyes were classified as group D and 6 eyes as group E. Each affected eye received a mean of 5.0±1.7 intravitreal injections, with a total melphalan dose of 111.1±44.5 μg and a total topotecan dose of 74.7±44.0 μg per eye. During the follow-up period, vitreous seeds in all affected eyes in both groups were controlled (100%), and no orbital or systemic metastases were observed. Compared with the double-drug group, the single-drug group exhibited fewer local adverse effects. The incidence of cataract was 0/15 and 9/19, while the incidence of phthisis bulbi was 0/","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"61 11","pages":"871-878"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145497056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华眼科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1